CBX8 antagonizes the effect of Sirtinol on premature senescence through the AKT-RB-E2F1 pathway in K562 leukemia cells
Authors:
- 1 January 2016
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 469 (4) , 884-890
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education (2009-0064593, 2014R1A1A2059608)
- Ministry of Science, ICT and Future Planning (2012R1A2A2A01003013)
This publication has 36 references indexed in Scilit:
- Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cellsOncotarget, 2014
- Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinibBlood, 2014
- Oncogenic signaling: new insights and controversies from chronic myeloid leukemiaJournal of Experimental Medicine, 2007
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- The signals and pathways activating cellular senescenceThe International Journal of Biochemistry & Cell Biology, 2005
- Characterization of AMN107, a selective inhibitor of native and mutant Bcr-AblCancer Cell, 2005
- Overriding Imatinib Resistance with a Novel ABL Kinase InhibitorScience, 2004
- Molecular mechanisms of transformation by the BCR-ABL oncogeneSeminars in Hematology, 2003
- Morphological and functional characteristics of short-term and long-term bone marrow cultures in chronic myelogenous leukemiaAmerican Journal of Hematology, 1999
- The serial cultivation of human diploid cell strainsExperimental Cell Research, 1961